First clinical trial of an automated blood drawing and testing device
In the future, robots could take blood samples, benefiting patients and healthcare workers alike.
A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
The device provides quick results and would allow healthcare professionals to spend more time treating patients in hospitals and other settings.
The results, published in the journal Technology, were comparable to or exceeded clinical standards, with an overall success rate of 87% for the 31 participants whose blood was drawn. For the 25 people whose veins were easy to access, the success rate was 97%.
The device includes an ultrasound image-guided robot that draws blood from veins. A fully integrated device, which includes a module that handles samples and a centrifuge-based blood analyzer, could be used at bedsides and in ambulances, emergency rooms, clinics, doctors’ offices and hospitals.
Venipuncture, which involves inserting a needle into a vein to get a blood sample or perform IV therapy, is the world’s most common clinical procedure, with more than 1.4 billion performed yearly in the United States. But clinicians fail in 27% of patients without visible veins, 40% of patients without palpable veins and 60% of emaciated patients, according to previous studies.
Repeated failures to start an IV line boost the likelihood of phlebitis, thrombosis and infections, and may require targeting large veins in the body or arteries – at much greater cost and risk. As a result, venipuncture is among the leading causes of injury to patients and clinicians. Moreover, a hard time accessing veins can increase procedure time by up to an hour, requires more staff and costs more than $4 billion a year in the United States, according to estimates.
“A device like ours could help clinicians get blood samples quickly, safely and reliably, preventing unnecessary complications and pain in patients from multiple needle insertion attempts,” said lead author Josh Leipheimer, a biomedical engineering doctoral student in the Yarmush lab in the biomedical engineering department in the School of Engineering at Rutgers University–New Brunswick.
In the future, the device could be used in such procedures as IV catheterization, central venous access, dialysis and placing arterial lines. Next steps include refining the device to improve success rates in patients with difficult veins to access. Data from this study will be used to enhance artificial intelligence in the robot to improve its performance.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Wildlife group pushes to end bird killing at fish hatcheryon April 4, 2021 at 7:19 am
The group has cooperated with banding and blood sampling of chicks to study environmental pollutants and survival. They’ve erected nesting platforms and launched a baling twine collection program.
- Ultra-fast proteomics with Scanning SWATHon March 24, 2021 at 4:59 pm
Exclusion criteria were refusal to participate in the clinical study by the patient or their legal representative, or clinical conditions that do not allow for blood sampling. The study assessed ...
- President Putin sees several pilot projects at ASI exhibitionon January 15, 2019 at 9:55 am
Among other leading developments of Russian manufacturers presented at the ASI exhibition were a prototype of an unmanned agricultural combine, an innovative device for capillary blood sampling ...
- Polyurethane Channelon February 19, 2018 at 9:28 pm
Uses include bile sampling, simultaneous infusion and blood sampling or simultaneous infusion and blood pressure measurement in rats. Install the VAHD115AB harness at the ...
- New space mission crew to hold about 50 experiments in orbiton August 22, 2016 at 8:29 am
We’ll be doing blood sampling and ultrasound scanning of various ... Russian Army to set up first military unit armed with strike robots Russia’s Defense Minister Sergei Shoigu inspected ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Automated blood drawing and testing
- Todos Medical acquires Provista Diagnostics and its breast cancer... Todos Medical acquires Provista Diagnostics and its breast cancer...on April 22, 2021 at 8:55 am
The results provided by the test have demonstrated specificity of 98%-plus in both women over and under the age of 50 ...
- Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Teston April 22, 2021 at 8:42 am
Todos plans to commercialize Videssa in late 2021 to reduce unnecessary biopsies in the $7.19 billion mammogram naïve market and integrate it ...
- Blood Centers of America Recognizes Outstanding Partners During the COVID-19 Pandemic With Critical Infusion Awardon April 21, 2021 at 10:14 am
Stock quotes by finanzen.net WEST WARWICK, R.I., April 21, 2021 /PRNewswire/ -- Citing exceptional efforts and partnership, Blood Centers of America (BCA) is recognizing 10 of its supply partners with ...
- Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?on April 20, 2021 at 5:36 am
To monitor antibody level duration of vaccine-induced immune responses, a team of researchers in the U.S. – at Diacarta, University of California and VA Healthcare System, and the Franciscan ...
- New Study Establishes Cytovale IntelliSep Test in the Rapid Diagnosis of Sepsison April 19, 2021 at 4:01 am
Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune mediated diseases, today announced the publication of a study in the ...